搜索筛选:
搜索耗时3.0340秒,为你在为你在102,285,761篇论文里面共找到 28 篇相符的论文内容
发布年度:
challenge to overcome:Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy
[期刊论文] 作者：Ken Sato,Toshio Uraoka,
来源：世界胃肠病学杂志：英文版 年份：2018
Interferon(IFN)-based therapy for hepatitis C virus(HCV)infection has recently been replaced by IFNfree direct-acting antiviral(DAA)-based therapy,which has bee...
[期刊论文] 作者：Ken Sato,Masatoshi Yanagisawa,,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2013
We devised an extended 72-wk peginterferon--2a/ribavirin therapy regimen for the retreatment of highly intractable cases,i.e.,48-wk peginterferon--2b/ribavirin...
Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination th
[期刊论文] 作者：Takayoshi Suga,Ken Sato,Yuichi,
来源：世界临床病例杂志 年份：2015
A 66-year-old,interferon-ineligible,treatment-naive man who was diagnosed with chronic hepatitis C due to hepatitis C virus genotype 1b began combination therap...
[期刊论文] 作者：Takayoshi Suga,Ken Sato,Tatsuy,
来源：世界肝病学杂志:英文版(电子版) 年份：2020
BACKGROUND Sodium glucose cotransporter 2(SGLT2)inhibitors are newly developed oral antidiabetic drugs.SGLT2 is primarily expressed in the kidneys and reabsorbs...
Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C
[期刊论文] 作者：Ken Sato,Yuichi Yamazaki,Tatsu,
来源：世界临床病例杂志 年份：2016
The standard antiviral therapy for dialysis patients infected with hepatitis C virus(HCV)is(pegylated)interferon monotherapy,but its efficacy is insufficient.Or...
[期刊论文] 作者：Ken Sato Hiroaki Okamoto,Yuich,
来源：世界临床病例杂志 年份：2019
BACKGROUND The effectiveness of sofosbuvir/ribavirin (SOF/RBV) combination therapy, which is one of the 1st-choice therapeutic options for patients with hepatit...
[期刊论文] 作者：Tatsuya Ohyama,Ken Sato,Yuichi,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2014
AIM:To investigate the mechanism and in vivo effects of MK-0626,a dipeptidyl peptidase-4 inhibitor,on hepatic steatosis using ob/ob mice.METHODS:We analyzed obe...
Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C pat
[期刊论文] 作者：Hideyuki Suzuki Ken Sato Hitos,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2006
瞄准：为长期的丙肝的治疗在高病毒的负担的肝炎病毒遗传型 1b 被表明了的干扰素的功效上的锌补充的有益的效果。这研究与遗传型 2 集中于病人，它比遗传型 1b 对干扰素更敏感，并......
Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis： Case repo
[期刊论文] 作者：Hiroshi Koide,Ken Sato,Toshio,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2006
肝的煽动性的假肿瘤(IPT ) 是煽动性的房间渗入的增殖的纤维组织描绘的稀罕良性的非肿瘤的损害。IPT 的准确病原学仍然保持不清楚。尽管有全身的煽动性的混乱的 IPT 的协会很...
Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C pat
[期刊论文] 作者：Hideyuki Suzuki,Ken Sato,Hitos,
来源：世界胃肠病学杂志（英文版） 年份：2004
AIM: The beneficial effect of zinc supplementation on the efficacy of interferon as a treatment for chronic hepatitis C had been demonstrated in hepatitis virus...
[期刊论文] 作者：Satoru Kakizaki,Hitoshi Takagi,Yuichi Yamazaki,Naondo Sohara,Ken Sato,Takeaki Nagamine,Masatomo Mori,,
来源：World Journal of Gastroenterology 年份：2006
The outcome of infection with hepatitis C virus(HCV)varies substantially from self-limiting infection to chronichepatitis,liver cirrhosis,and hepatocellular ca...
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepat
[期刊论文] 作者：Hideyuki Suzuki,Hitoshi Takagi,Naondo Sohara,Daisuke Kanda,Satoru Kakizaki,Ken Sato,Masatomo Mori,,
来源：World Journal of Gastroenterology 年份：2006
AIM:To study the therapeutic effect of interferon(IFN)and ribavirin with zinc supplement on patients withchronic hepatitis C viral(HCV)infection.METHODS:A tota...
[期刊论文] 作者：Hideyuki Suzuki,Satoru Kakizaki,Norio Horiguchi,Takeshi Ichikawa,Ken Sato,Hitoshi Takagi,Masatomo Mori,
来源：World Journal of Hepatology 年份：2010
AIM: To predict which chronic hepatitis C patients are likely to be late-responders, we herein investigated the clinical characteristics of null-responders at 3...
Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepat
[期刊论文] 作者：Hideyuki Suzuki,Hitoshi Takaqi,Naondo Sohara,Daisuke Kanda,Satoru Kakizaki,Ken Sato,Masatomo Mori,
来源：世界胃肠病学杂志（英文版） 年份：2006
AIM: To study the therapeutic effect of interferon (IFN)and ribavirin with zinc supplement on patients with chronic hepatitis C viral (HCV) infection.METHODS: A...
[会议论文] 作者：GOTO Shigemi,SATO Natsu,MIYAZA WA Ken,SATO Yosuke,MASUDA Takehiro,KA WAI Tatsushi,HAYASHI Tatsuhide,
来源：第四届中日口腔医学大会(The Fourth Sino-Japanese Conference on Stomatolo 年份：2008
...
Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C
[期刊论文] 作者：Ken Sato,Yuichi Yamazaki,Tatsuya Ohyama,Takeshi Kobayashi,Norio Horiguchi,Satoru Kakizaki,Motoyasu Kusano,
来源：World Journal of Clinical Cases 年份：2016
The standard antiviral therapy for dialysis patients infected with hepatitis C virus(HCV) is(pegylated) interferon monotherapy, but its efficacy is insufficient...
Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination th
[期刊论文] 作者：Takayoshi Suga,Ken Sato,Yuichi Yamazaki,Tatsuya Ohyama,Norio Horiguchi,Satoru Kakizaki,Motoyasu Kusano,
来源：World Journal of Clinical Cases 年份：2015
A 66-year-old, interferon-ineligible, treatment-naive man who was diagnosed with chronic hepatitis C due to hepatitis C virus genotype 1b began combination ther...
[期刊论文] 作者：Tetsu Endo,Juichi Sakamoto,Ken Sato,Miyako Takimoto,Koji Shimaya,Tatsuya Mikami,Akihiro Munakata,Tadashi,
来源：World Journal of Gastroenterology 年份：2005
Acute esophageal necrosis (AEN) is extremely rare and the pathogenesis of this is still unknown. We report a case of AEN caused by alcohol abuse. In our case, t...
Advanced hepatocellular carcinoma responds to MK615,a compound extract from the Japanese apricot “Pr
[期刊论文] 作者：Hoshino,Hitoshi Takagi,Atsushi Naganuma,Eri Koitabashi,Sanae Uehara,Naomi Sakamoto,Tomohiro Kudo,Ken Sato,
来源：World Journal of Hepatology 年份：2013
MK615, a compound extracted from the Japanese apricot “Prunus mume ” has been reported to have in vitro anti-tumor activities against several cancer cell line...
[期刊论文] 作者：Tatsuya Ohyama,Ken Sato,Yuichi Yamazaki,Hiroaki Hashizume,Norio Horiguchi,Satoru Kakizaki,Masatomo Mori,
来源：World Journal of Gastroenterology 年份：2014
AIM:To investigate the mechanism and in vivo effects of MK-0626,a dipeptidyl peptidase-4 inhibitor,on hepatic steatosis using ob/ob mice.METHODS:We analyzed obe...
相关搜索：
